BioCentury
ARTICLE | Clinical News

Beteflam Patch regulatory update

March 16, 2015 7:00 AM UTC

Health Canada accepted for review an NDS for Beteflam Patch from Cipher Pharmaceuticals Inc. (TSX:CPH; NASDAQ:CPHR, Mississauga, Ontario) to treat inflammatory skin conditions, including chronic plaq...